RT Journal Article
SR Electronic
T1 Microscale dynamics of electrophysiological markers of epilepsy
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.14.20211649
DO 10.1101/2020.10.14.20211649
A1 Jimmy C. Yang
A1 Angelique C. Paulk
A1 Sang Heon Lee
A1 Mehran Ganji
A1 Daniel J. Soper
A1 Pariya Salami
A1 Daniel Cleary
A1 Mirela Simon
A1 Douglas Maus
A1 Jong Woo Lee
A1 Brian Nahed
A1 Pamela Jones
A1 Daniel P. Cahill
A1 Garth Rees Cosgrove
A1 Catherine J. Chu
A1 Ziv Williams
A1 Eric Halgren
A1 Shadi Dayeh
A1 Sydney S. Cash
YR 2020
UL http://medrxiv.org/content/early/2020/10/16/2020.10.14.20211649.abstract
AB Objective Interictal discharges (IIDs) and high frequency oscillations (HFOs) are neurophysiologic biomarkers of epilepsy. In this study, we use custom poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) microelectrodes to better understand their microscale dynamics.Methods Electrodes with spatial resolution down to 50µm were used to record intraoperatively in 30 subjects. For IIDs, putative spatiotemporal paths were generated by peak-tracking, followed by clustering. For HFOs, repeating patterns were elucidated by clustering similar time windows. Fast events, consistent with multi-unit activity (MUA), were covaried with either IIDs or HFOs.Results IIDs seen across the entire array were detected in 93% of subjects. Local IIDs, observed across <50% of the array, were seen in 53% of subjects. IIDs appeared to travel across the array in specific paths, and HFOs appeared in similar repeated spatial patterns. Finally, microseizure events were identified spanning 50-100µm. HFOs covaried with MUA, but not with IIDs.Conclusions Overall, these data suggest micro-domains of irritable cortex that form part of an underlying pathologic architecture that contributes to the seizure network.Significance Microelectrodes in cases of human epilepsy can reveal dynamics that are not seen by conventional electrocorticography and point to new possibilities for their use in the diagnosis and treatment of epilepsy.HighlightsPEDOT:PSS microelectrodes with at least 50µm spatial resolution uniquely reveal spatiotemporal patterns of markers of epilepsyHigh spatiotemporal resolution allows interictal discharges to be tracked and reveal cortical domains involved in microseizuresHigh frequency oscillations detected by microelectrodes demonstrate localized clustering on the cortical surfaceCompeting Interest StatementDPC has received consulting fees from Lilly and Boston Pharmaceuticals, and has received honoraria and travel reimbursement from Merck for invited lectures and from the NIH and DOD for clinical trial and grant review. The other authors report no potential conflicts of interest to be disclosed.Funding StatementThis research was sponsored by the U.S. Army Research Office and Defense Advanced Research Projects Agency under Cooperative Agreement Number W911NF-14-2-0045. In addition, other support included ECOR and K24-NS088568 to SSC; NSF-CAREER award #1351980, NSF CMMI award #1728497, and NIH DP2-EB029757 to SAD. The views and conclusions contained in this document are those of the authors and do not represent the official policies, either expressed or implied, of the funding sources.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Recordings were performed in subjects who were already scheduled for a neurosurgical procedure at Massachusetts General Hospital (MGH) or Brigham and Women's Hospital (BWH). This study was approved by the Partners Institutional Review Board, which covers both MGH and BWH. All subjects voluntarily participated and provided informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the senior author, upon reasonable request.